Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials.

Han YJ, Lee KH, Yoon S, Nam SW, Ryu S, Seong D, Kim JS, Lee JY, Yang JW, Lee J, Koyanagi A, Hong SH, Dragioti E, Radua J, Smith L, Oh H, Ghayda RA, Kronbichler A, Effenberger M, Kresse D, Denicolò S, Kang W, Jacob L, Shin H, Shin JI

Open source

DOI: 10.7150/thno.48342
Published: 2021
Container: Theranostics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7150/thno.48342,
  title = {Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials.},
  author = {Han YJ and Lee KH and Yoon S and Nam SW and Ryu S and Seong D and Kim JS and Lee JY and Yang JW and Lee J and Koyanagi A and Hong SH and Dragioti E and Radua J and Smith L and Oh H and Ghayda RA and Kronbichler A and Effenberger M and Kresse D and Denicolò S and Kang W and Jacob L and Shin H and Shin JI},
  year = {2021},
  journal = {Theranostics},
  doi = {10.7150/thno.48342},
  url = {https://doi.org/10.7150/thno.48342}
}

RIS

TY  - JOUR
TI  - Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials.
AU  - Han YJ
AU  - Lee KH
AU  - Yoon S
AU  - Nam SW
AU  - Ryu S
AU  - Seong D
AU  - Kim JS
AU  - Lee JY
AU  - Yang JW
AU  - Lee J
AU  - Koyanagi A
AU  - Hong SH
AU  - Dragioti E
AU  - Radua J
AU  - Smith L
AU  - Oh H
AU  - Ghayda RA
AU  - Kronbichler A
AU  - Effenberger M
AU  - Kresse D
AU  - Denicolò S
AU  - Kang W
AU  - Jacob L
AU  - Shin H
AU  - Shin JI
PY  - 2021
JO  - Theranostics
DO  - 10.7150/thno.48342
UR  - https://doi.org/10.7150/thno.48342
ER  -

APA

YJ, H., KH, L., S, Y., SW, N., S, R., D, S., JS, K., JY, L., JW, Y., J, L., A, K., SH, H., E, D., J, R., L, S., H, O., RA, G., A, K., M, E., D, K., S, D., W, K., L, J., H, S., & JI, S. (2021). Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials.. Theranostics. https://doi.org/10.7150/thno.48342

Source records

pubmed · retrieved 2026-09-26T16:22:49.344Z